Mark Giembycz
Mark Giembycz
Professor of Pulmonary Pharmacology, University of Calgary
Verified email at
Cited by
Cited by
Experimental design and analysis and their reporting II: Updated and simplified guidance for authors and peer reviewers
MJ Curtis, S Alexander, G Cirino, JR Docherty, CH George, MA Giembycz, ...
British journal of pharmacology 175 (7), 987-993, 2018
Experimental design and analysis and their reporting: new guidance for publication in BJP
MJ Curtis, RA Bond, D Spina, A Ahluwalia, SPA Alexander, MA Giembycz, ...
British journal of pharmacology 172 (14), 3461, 2015
Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology
SPH Alexander, RE Roberts, BRS Broughton, CG Sobey, CH George, ...
British journal of pharmacology 175 (3), 407, 2018
Pharmacology of the eosinophil
MA Giembycz, MA Lindsay
Pharmacological reviews 51 (2), 213-340, 1999
Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4
KM Beeh, O Kornmann, R Buhl, SV Culpitt, MA Giembycz, PJ Barnes
Chest 123 (4), 1240-1247, 2003
Delayed eosinophil apoptosis in asthma
H Kankaanranta, MA Lindsay, MA Giembycz, X Zhang, E Moilanen, ...
Journal of Allergy and Clinical Immunology 106 (1), 77-83, 2000
Identification of cyclic AMP phosphodiesterases 3, 4 and 7 in human CD4+ and CD8+ T‐lymphocytes: role in regulating proliferation and the biosynthesis of …
MA Giembycz, CJ Corrigan, J Seybold, R Newton, PJ Barnes
British journal of pharmacology 118 (8), 1945-1958, 1996
Differential regulation of cytokine release and leukocyte migration by lipopolysaccharide-stimulated primary human lung alveolar type II epithelial cells and macrophages
AJ Thorley, PA Ford, MA Giembycz, P Goldstraw, A Young, TD Tetley
The journal of immunology 178 (1), 463-473, 2007
Protein kinase C isoenzymes: a review of their structure, regulation and role in regulating airways smooth muscle tone and mitogenesis
BLJ Webb, SJ Hirst, MA Giembycz
British journal of pharmacology 130 (7), 1433, 2000
Phosphodiesterase 4 inhibitors and the treatment of asthma: where are we now and where do we go from here?
MA Giembycz
Drugs 59, 193-212, 2000
Beyond the dogma: novel β2-adrenoceptor signalling in the airways
MA Giembycz, R Newton
European Respiratory Journal 27 (6), 1286-1306, 2006
Prostanoid receptor antagonists: development strategies and therapeutic applications
RL Jones, MA Giembycz, DF Woodward
British journal of pharmacology 158 (1), 104-145, 2009
Long-acting β2-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells
M Kaur, JE Chivers, MA Giembycz, R Newton
Molecular pharmacology 73 (1), 203-214, 2008
Discovery of BRL 50481 [3-(N, N-dimethylsulfonamido)-4-methyl-nitrobenzene], a selective inhibitor of phosphodiesterase 7: in vitro studies in human monocytes, lung macrophages …
SJ Smith, LB Cieslinski, R Newton, LE Donnelly, PS Fenwick, ...
Molecular pharmacology 66 (6), 1679-1689, 2004
Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD
MA Giembycz, SK Field
Drug design, development and therapy, 147-158, 2010
Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with …
PM Seldon, PJ Barnes, K Meja, MA Giembycz
Molecular Pharmacology 48 (4), 747-757, 1995
Inhibition of eosinophil cyclic nucleotide PDE activity and opsonised zymosan‐stimulated respiratory burst by ‘type IV’‐selective PDE inhibitors
G Dent, MA Giembycz, KF Rabe, PJ Barnes
British journal of pharmacology 103 (2), 1339-1346, 1991
Cilomilast: a second generation phosphodiesterase 4 inhibitor for asthma and chronic obstructive pulmonary disease
MA Giembycz
Expert opinion on investigational drugs 10 (7), 1361-1379, 2001
Release of granulocyte‐macrophage colony stimulating factor by human cultured airway smooth muscle cells: suppression by dexamethasone
MA Saunders, JA Mitchell, PM Seldon, MH Yacoub, PJ Barnes, ...
British journal of pharmacology 120 (4), 545-546, 1997
A Holy Grail of asthma management: toward understanding how long‐acting β2‐adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids
MA Giembycz, M Kaur, R Leigh, R Newton
British journal of pharmacology 153 (6), 1090-1104, 2008
The system can't perform the operation now. Try again later.
Articles 1–20